Characterization of FR 172357, a new non-peptide bradykinin B 2 receptor antagonist, in human, pig and rabbit preparations

By Rizzi C.   Rizzi A.   Calo G.   Jorizzo G.   Agnello G.   Mollica G.   Inamura N.   Regoli D.  

European Journal of Pharmacology, Vol. 386, Iss. 1, 1999-12 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B 2 receptor antagonist, FR167344

By Inamura N.   Asano M.   Hatori C.   Sawai H.   Jiro Hirosumi   Fujiwara T.   Kayakiri H.   Satoh S.   Abe Y.   Inoue T.   Sawada Y.   Oku T.   Nakahara K.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

Effect of FK3657, a non-peptide bradykinin B 2 receptor antagonist, on allergic airway disease models

By Hirayama Y.   Miyayasu K.   Yamagami K.   Imai T.   Ohkubo Y.   Mutoh S.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite

Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 913-928

Bentham Science Publishers

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite